Recent Finacing
Recent Raise
Appello Pharmaceuticals is a preclinical-stage biopharma developing mGlu4-specific positive allosteric modulators licensed from Vanderbilt for Parkinson’s disease, based in Nashville.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Appello Pharmaceuticals.
